mucositis K12.3
Conditions
Interventions
Group 1: Patients with oncological primary disease and stem cell transplantation
Mouthwash solution with Glandomed(Chlorhexidine digluconate) according to individual maintenance plan (5 x mouthwash) f
Sponsors
Fa. Schülke GmbH
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: • Participants> 18 years • Signed declaration of consent to participate or Written declaration of consent by the supervisor • German speaking • oncological patients (KMT autologous or allogeneic)
Exclusion criteria
Exclusion criteria: • Mental disorders • Existing mucositis before radiation therapy / chemotherapy • Current therapy with chemotherapy or irradiation • Incompatibility with CHX or octenidine • Temperatures> 38 degrees Celsius before irradiation / chemotherapy • Dental defect or loose teeth • Infection of the upper respiratory tract
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| State of mucositis by standardc scores.OMAS-Skala (Oral mucositis assessment scoale) and WHO-Skala zur Mucositis)The parameters are measured at three times in day 0, day 3, day 5 and day 14 in the morning) | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain (visuel analogue scale), difficulties in swallowing, temperature, microbiological tests of saliva (bacterial material)The parameters are measured at three times, in day 0, day 3 day 5 and day 14 in the morning) | — |
Countries
Germany
Contacts
Public ContactThomas Neubert
Universitätsklinikum Giessen und Marburg GmbH
Outcome results
None listed